J Korean Med Sci.  2014 Jan;29(1):12-22. 10.3346/jkms.2014.29.1.12.

Evidence-Based, Non-Pharmacological Treatment Guideline for Depression in Korea

• Park SC
• Oh HS
• Oh DH
• Jung SA
• Na KS
• Lee HY
• Kang RH
• Choi YK
• Lee MS
• Park YC

• KMID: 1796909
• DOI: http://doi.org/10.3346/jkms.2014.29.1.12

Abstract

Although pharmacological treatment constitutes the main therapeutic approach for depression, non-pharmacological treatments (self-care or psychotherapeutic approach) are usually regarded as more essential therapeutic approaches in clinical practice. However, there have been few clinical practice guidelines concerning self-care or psychotherapy in the management of depression. This study introduces the 'Evidence-Based, Non-Pharmacological Treatment Guideline for Depression in Korea.' For the first time, a guideline was developed for non-pharmacological treatments for Korean adults with mild-to-moderate depression. The guideline development process consisted of establishing several key questions related to non-pharmacologic treatments of depression, searching the literature for studies which answer these questions, assessing the evidence level of each selected study, drawing up draft recommendation, and peer review. The Scottish Intercollegiate Guidelines Network grading system was used to evaluate the quality of evidence. As a result of this process, the guideline recommends exercise therapy, bibliotherapy, cognitive behavior therapy, short-term psychodynamic supportive psychotherapy, and interpersonal psychotherapy as the non-pharmacological treatments for adult patients with mild-to-moderate depression in Korea. Hence, it is necessary to develop specific methodologies for several non-pharmacological treatment for Korean adults with depression.

Keyword

Depression; Non-Pharmacological Treatment; Self-Care; Psychotherapy; Guideline; Korea

MeSH Terms

Adult
Bibliotherapy/*methods
Clinical Protocols
Cognitive Therapy/*methods
Combined Modality Therapy/*methods
Depression/*drug therapy/psychology/*therapy
Exercise Therapy
Humans
Placebos/therapeutic use
Questionnaires
Republic of Korea
Placebos

Reference

1. Oh DH, Kim SA, Lee HY, Seo JY, Choi BY, Nam JH. Prevalence and correlates of depressive symptoms in Korean adults: results of a 2009 Korean community health survey. J Korean Med Sci. 2013; 28:128–135.

2. Lopez AD, Mathers CD, Ezzati M, Jamison DT, Murray CJL. Global burden of disease and risk factors. Washington, D.C.: World Bankm;2006.

3. Jeon HJ. Epidemiologic studies on depression and suicide. J Korean Med Assoc. 2012; 55:322–328.

4. Lim SW, Lee MS. Korean clinical practice guideline for the treatment of depressive disorders: the present state and future direction of development. Korean J Biol Psychiatry. 2006; 13:11–18.

5. Kang RH, Kim SY, Lee MS. Korean clinical practice guideline for the treatment of depressive disorders (II). Korean J Biol Psychiatry. 2006; 13:219–225.

6. Kim TS, Jeong SH, Kim JB, Lee MS, Kim JM, Yim HW, Jun TY. The clinical research center for depression study: baseline characteristics of a Korean long-term hospital-based observational collaborative prospective cohort study. Psychiatry Investig. 2011; 8:1–8.

7. Park SC, Sung SH, Han KM, Won ES, Lee HY, Paik JW, Jeon HJ, Lee MS, Shim SH, Ko YH, et al. Evidence-based Korean pharmacological treatment guideline for depression, revised edition (I): initial choice of antidepressant treatment. J Korean Neuropsychiatr Assoc. 2013; 52:253–262.

8. Oh HS, Lee HW, Park YC. The current status and requirements for non-pharmacological treatment of depression in Korea. Korean J Biol Psychiatry. 2007; 14:21–27.

9. American Psychiatric Association. Diagnostic and statistical manual of mental disorders. 4th ed. Washington, D.C.: American Psychiatric Association;1994.

10. Babyak M, Blumenthal JA, Herman S, Khatri P, Doraiswamy M, Moore K, Craighead WE, Baldewicz TT, Krishnan KR. Exercise treatment for major depression: maintenance of therapeutic benefit at 10 months. Psychosom Med. 2000; 62:633–638.

11. Blumenthal JA, Babyak MA, Doraiswamy PM, Watkins L, Hoffman BM, Barbour KA, Herman S, Craighead WE, Brosse AL, Waugh R, et al. Exercise and pharmacotherapy in the treatment of major depressive disorder. Psychosom Med. 2007; 69:587–596.

12. Cramer SR, Nieman DC, Lee JW. The effects of moderate exercise training on psychological well-being and mood state in women. J Psychosom Res. 1991; 35:437–449.

13. Dunn AL, Trivedi MH, Kampert JB, Clark CG, Chambliss HO. Exercise treatment for depression: efficacy and dose response. Am J Prev Med. 2005; 28:1–8.

14. Greist JH, Klein MH, Eischens RR, Faris J, Gurman AS, Morgan WP. Running as treatment for depression. Compr Psychiatry. 1979; 20:41–54.

15. Krogh J, Saltin B, Gluud C, Nordentoft M. The DEMO trial: a randomized, parallel-group, observer-blinded clinical trial of strength versus aerobic versus relaxation training for patients with mild to moderate depression. J Clin Psychiatry. 2009; 70:790–800.

16. Legrand F, Heuze JP. Antidepressant effects associated with different exercise conditions in participants with depression: a pilot study. J Sport Exerc Psychol. 2007; 29:348–364.

17. McCann IL, Holmes DS. Influence of aerobic exercise on depression. J Pers Soc Psychol. 1984; 46:1142–1147.

18. Nabkasorn C, Miyai N, Sootmongkol A, Junprasert S, Yamamoto H, Arita M, Miyashita K. Effects of physical exercise on depression, neuroendocrine stress hormones and physiological fitness in adolescent females with depressive symptoms. Eur J Public Health. 2006; 16:179–184.

19. Singh NA, Clements KM, Singh MA. The efficacy of exercise as a long-term antidepressant in elderly subjects: a randomized, controlled trial. J Gerontol A Biol Sci Med Sci. 2001; 56:M497–M504.

20. Dunn AL, Trivedi MH, O'Neal HA. Physical activity dose-response effects on outcomes of depression and anxiety. Med Sci Sports Exerc. 2001; 33:S587–S597.

21. Ernst E, Rand JI, Stevinson C. Complementary therapies for depression: an overview. Arch Gen Psychiatry. 1998; 55:1026–1032.

22. Lawlor DA, Hopker SW. The effectiveness of exercise as an intervention in the management of depression: systematic review and meta-regression analysis of randomised controlled trials. BMJ. 2001; 322:763–767.

23. Mead GE, Morley W, Campbell P, Greig CA, McMurdo M, Lawlor DA. Exercise for depression. Cochrane Database Syst Rev. 2009; 3:CD004366.

24. Morgan AJ, Jorm AF. Self-help interventions for depressive disorders and depressive symptoms: a systematic review. Ann Gen Psychiatry. 2008; 7:13.

25. Rethorst CD, Wipfli BM, Landers DM. The antidepressive effects of exercise: a meta-analysis of randomized trials. Sports Med. 2009; 39:491–511.

26. Teychenne M, Ball K, Salmon J. Physical activity and likelihood of depression in adults: a review. Prev Med. 2008; 46:397–411.

27. Wollersheim JP, Wilson GL. Group treatment of unipolar depression: a comparison of coping, supportive, bibliotherapy, and delayed treatment groups. Prof Psychol Res Pr. 1991; 22:496–502.

28. Bowman D, Scogin F, Lyrene B. The efficacy of self-examination therapy and cognitive bibliotherapy in the treatment of mild-to-moderate depression. Psychother Res. 1995; 5:131–140.

29. Jamison C, Scogin F. The outcome of cognitive bibliotherapy with depressed adults. J Consult Clin Psychol. 1995; 63:644–650.

30. Mead N, MacDonald W, Bower P, Lovell K, Richards D, Roberts C, Bucknall A. The clinical effectiveness of guided self-help versus waiting-list control in the management of anxiety and depression: a randomized controlled trial. Psychol Med. 2005; 35:1633–1643.

31. Anderson L, Lewis G, Araya R, Elgie R, Harrison G, Proudfoot J, Schmidt U, Sharp D, Weightman A, Williams C. Self-help books for depression: how can practitioners and patients make the right choice? Br J Gen Pract. 2005; 55:387–392.

32. Fanner D, Urquhart C. Bibliotherapy for mental health service users Part 1: a systematic review. Health Info Libr J. 2008; 25:237–252.

33. McNaughton JL. Brief interventions for depression in primary care: a systematic review. Can Fam Physician. 2009; 55:789–796.

34. Wong DF. Cognitive behavioral treatment groups for people with chronic depression in Hong Kong: a randomized wait-list control design. Depress Anxiety. 2008; 25:142–148.

35. Wong DF. Cognitive and health-related outcomes of group cognitive behavioural treatment for people with depressive symptoms in Hong Kong: randomized wait-list control study. Aust N Z J Psychiatry. 2008; 42:702–711.

36. Dimidjian S, Hollon SD, Dobson KS, Schmaling KB, Kohlenberg RJ, Addis ME, Gallop R, McGlinchey JB, Markley DK, Gollan JK, et al. Randomized trial of behavioral activation, cognitive therapy, and antidepressant medication in the acute treatment of adults with major depression. J Consult Clin Psychol. 2006; 74:658–670.

37. Ward E, King M, Lloyd M, Bower P, Sibbald B, Farrelly S, Gabbay M, Tarrier N, Addington-Hall J. Randomised controlled trial of non-directive counselling, cognitive-behaviour therapy, and usual general practitioner care for patients with depression: I: clinical effectiveness. BMJ. 2000; 321:1383–1388.

38. Elkin I, Shea MT, Watkins JT, Imber SD, Sotsky SM, Collins JF, Glass DR, Pilkonis PA, Leber WR, Docherty JP, et al. National Institute of Mental Health Treatment of Depression Collaborative Research Program: general effectiveness of treatments. Arch Gen Psychiatry. 1989; 46:971–982.

39. Gloaguen V, Cottraux J, Cucherat M, Blackburn IM. A meta-analysis of the effects of cognitive therapy in depressed patients. J Affect Disord. 1998; 49:59–72.

40. Parker GB, Crawford J, Hadzi-Pavlovic D. Quantified superiority of cognitive behaviour therapy to antidepressant drugs: a challenge to an earlier meta-analysis. Acta Psychiatr Scand. 2008; 118:91–97.

41. De Jonghe F, Hendricksen M, van Aalst G, Kool S, Peen V, Van R, van den Eijnden E, Dekker J. Psychotherapy alone and combined with pharmacotherapy in the treatment of depression. Br J Psychiatry. 2004; 185:37–45.

42. De Jonghe F, Kool S, van Aalst G, Dekker J, Peen J. Combining psychotherapy and antidepressants in the treatment of depression. J Affect Disord. 2001; 64:217–229.

43. Dekker JJ, Koelen JA, Van HL, Schoevers RA, Peen J, Hendriksen M, Kool S, Van Aalst G, De Jonghe F. Speed of action: the relative efficacy of short psychodynamic supportive psychotherapy and pharmacotherapy in the first 8 weeks of a treatment algorithm for depression. J Affect Disord. 2008; 109:183–188.

44. Dekker J, Molenaar PJ, Kool S, Van Aalst G, Peen J, de Jonghe F. Dose-effect relations in time-limited combined psycho-pharmacological treatment for depression. Psychol Med. 2005; 35:47–58.

45. Kool S, Dekker J, Duijsens IJ, de Jonghe F, Puite B. Changes in personality pathology after pharmacotherapy and combined therapy for depressed patients. J Pers Disord. 2003; 17:60–72.

46. Molenaar PJ, Dekker J, Van R, Hendriksen M, Vink A, Schoevers RA. Does adding psychotherapy to pharmacotherapy improve social functioning in the treatment of outpatient depression? Depress Anxiety. 2007; 24:553–562.

47. De Maat S, Dekker J, Schoevers R, van Aalst G, Gijsbers-van Wijk C, Hendriksen M, Kool S, Peen J, Van R, de Jonghe F. Short psychodynamic supportive psychotherapy, antidepressants, and their combination in the treatment of major depression: a mega-analysis based on three randomized clinical trials. Depress Anxiety. 2008; 25:565–574.

48. DiMascio A, Weissman MM, Prusoff BA, Neu C, Zwilling M, Klerman GL. Differential symptom reduction by drugs and psychotherapy in acute depression. Arch Gen Psychiatry. 1979; 36:1450–1456.

49. Weissman MM, Prusoff BA, Dimascio A, Neu C, Goklaney M, Klerman GL. The efficacy of drugs and psychotherapy in the treatment of acute depressive episodes. Am J Psychiatry. 1979; 136:555–558.

50. De Mello MF, de Jesus Mari J, Bacaltchuk J, Verdeli H, Neugebauer R. A systematic review of research findings on the efficacy of interpersonal therapy for depressive disorders. Eur Arch Psychiatry Clin Neurosci. 2005; 255:75–82.

51. Lee SH, Park YC. Self care in depression. Korean J Biol Psychiatry. 2007; 14:5–13.

52. Wampold BE, Mondin GW, Moody M, Stich F, Benson K, Ahn H. A meta-analysis of outcome studies comparing bona fide psychotherapies: empirically, "all must have prizes". Psychol Bull. 1997; 122:203–215.

53. Roh S, Park YC. Characteristics of depression in Korea and non-pharmacological treatment. Korean J Biol Psychiatry. 2006; 13:226–233.

54. Van HL, Dekker J, Koelen J, Kool S, van Aalst G, Hendriksen M, Peen J, Schoevers R. Patient preference compared with random allocation in short-term psychodynamic supportive psychotherapy with indicated addition of pharmacotherapy for depression. Psychother Res. 2009; 19:205–212.

55. Huang X, Lin J, Demner-Fushman D. Evaluation of PICO as a knowledge representation for clinical questions. AMIA Annu Symp Proc. 2006; 2006:359–363.

56. Petrie JC, Grimshaw JM, Bryson A. The Scottish Intercollegiate Guidelines Network Initiative: getting validated guidelines into local practice. Health Bull (Edinb). 1995; 53:345–348.

57. Guyatt GH, Oxman AD, Kunz R, Falck-Ytter Y, Vist GE, Liberati A, Schünemann HJ. GRADE Working Group. Going from evidence to recommendations. BMJ. 2008; 336:1049–1051.

58. Jorm AF, Christensen H, Griffiths KM, Rodgers B. Effectiveness of complementary and self-help treatments for depression. Med J Aust. 2002; 176:S84–S96.

59. De Jonghe F, Rijnierse P, Janssen R. Psychoanalytic supportive psychotherapy. J Am Psychoanal Assoc. 1994; 42:421–446.

60. Cutler JL, Goldyne A, Markowitz JC, Devlin MJ, Glick RA. Comparing cognitive behavior therapy, interpersonal psychotherapy, and psychodynamic psychotherapy. Am J Psychiatry. 2004; 161:1567–1573.

61. Yang J, Han C, Yoon HK, Pae CU, Kim MJ, Park SY, Ahn J. Experiences and barriers to implementation of clinical practice guideline for depression in Korea. BMC psychiatry. 2013; 13:150.

62. Park YC, Kim KI. The psychiatric practices relevant to the Korean culture. Ment Health Res. 1998; 17:4–17.